Purity, ID & Quantitation
View the analytical report assigned to this product option.
View COA↗Imagine First
GLP-2T
GLP-2T
Regular price
$89.00
Regular price
Sale price
$89.00
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
GLP-2T is a dual-receptor research peptide associated with GIP and GLP-1 signaling pathways. Supplied in lyophilized form with clearly labeled 15 mg and 30 mg strengths for controlled laboratory study.
Choose one vial or save 10% with a three-vial option. Variant-specific analytical documentation can be viewed through the COA section when available.
For laboratory research use only.
Documentation
Certificate of Analysis
Select a product option to view its available documentation.
Endotoxin
View the endotoxin report assigned to this product option.
View COA↗Documentation applies only to the product option and lot identified in each report.
Research overview
One peptide, two incretin-receptor systems.
Published tirzepatide research examines signaling at both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor.
GIPRGIP-receptor activity is one component of the reported dual-agonist profile.
GLP-1RGLP-1-receptor activity forms the second component of the published profile.
LY3298176The development code used for tirzepatide in primary research literature.
Research associationTirzepatide / LY3298176
Receptor profileGIPR + GLP-1R
Presentations15MG and 30MG
Material formLyophilized powder
Compound Profile & Technical Overview
GLP-2T is associated with the published tirzepatide literature, where the molecule was developed under the code LY3298176. Primary pharmacology research characterizes tirzepatide as a fatty-acid-modified peptide with agonist activity at both GIP and GLP-1 receptors. Structural and signaling studies report an imbalanced, receptor-specific profile rather than two separate peptides. Imagine First supplies 15MG and 30MG lyophilized research presentations. Exact identity, analytical purity, measured content, and endotoxin results must be verified against the selected strength's current-batch documentation.
Storage requirements
Protect from lightKeep refrigerated after reconstitutionAvoid freeze/thaw cycles
Lyophilized powder-20°CStated stability: 24+ months
Reconstituted solution2-8°CStated stability: approximately 30 days
Sealed lyophilized vials are described as heat-stable; refrigeration or freezing of sealed vials is optional. The 2-8°C guidance applies after reconstitution. Always follow the lot-specific documentation when it differs.
Published Research & References
Research resources: discovery and clinical proof-of-concept research for LY3298176, dual-receptor signaling and biased agonism study, and structural determinants of dual incretin-receptor agonism. These sources describe published tirzepatide research and do not establish identity, safety, efficacy, or expected outcomes for independently supplied GLP-2T material.
Important research notice
This material is offered strictly for laboratory research use. It is not intended for human or veterinary use, food use, compounding, diagnosis, treatment, cure, or prevention of disease. Published tirzepatide findings are provided only as educational research context and do not establish equivalence to this independently supplied material.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, FOOD, COSMETIC, OR MEDICAL PRODUCT
